Source: Virtual Congress 2021 – Acute COVID - 19



Rating:

Share or cite this content

Citations should be made in the following way:
H. Richardson (Dundee, United Kingdom), J. Maccallum (Dundee, United Kingdom), K. Falconer (Dundee, United Kingdom), D. Cassidy (Dundee, United Kingdom), M. Long (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), Y. Giam (Dundee, United Kingdom), L. Delgado (Dundee, United Kingdom), T. Pembridge (Dundee, United Kingdom), B. Parcell (Dundee, United Kingdom), S. Haynes (Dundee, United Kingdom), H. Abo-Leyah (Dundee, United Kingdom), D. Connell (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom). Rapid diagnosis of bacterial co-infection and antimicrobial resistance in patients with SARS-Cov-2 infection. 3967

Member's Comments

No comment yet.

Related content which might interest you: Analysis of antibiotic resistance and enterococcal infections of low respiratory infection on patients in hospital Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 Evaluation of the multidrug resistant TB in children with HIV infection Source: Eur Respir J 2004; 24: Suppl. 48, 439s Year: 2004 The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019 Year: 2020 Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 Application of therapeutic pneumoperitoneum for multi-drug resistant cavitary TB in HIV – infected patients Source: Eur Respir J 2004; 24: Suppl. 48, 650s Year: 2004 Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Prevalence and antibiotic susceptibility of pathogens from analysis of respiratory samples Source: Eur Respir J 2007; 30: Suppl. 51, 405s Year: 2007 The etiology and antimicrobial drugs resistance of microorganisms in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 2s Year: 2006 Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011 Infection or colonisation: indicators to initiate antimycobacterial treatment in nontuberculous mycobacterial infections Source: Annual Congress 2010 - Advances in the diagnosis of tuberculosis and nontuberculous mycobacterial infections: a joint ERS and ATS symposium Year: 2010 Disseminated bacterial community-acquired pneumonia in patients at late stages of HIV infection Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Infective agents and their antibiotic susceptibility in patients with respiratory infections Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005 The incidence of pulmonary infection caused by atypical pathogens in non-HIV immunocompromised patients Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010 Biological resistance to beta-lactamic antibiotics in patients with respiratory infection in the prediction of efficiency of antibacterial therapy Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Antibiotic resistance in pulmonary infections: mechanisms and epidemiology Source: Eur Respir Monogr 2017; 75: 21-43 Year: 2017 Lower respiratory infection and antimicrobial resistance Source: International Congress 2018 – New challenges in tackling known diseases with the 10 ERS Principles for Lung Health Year: 2018